{"version":"1.0","type":"rich","provider_name":"Tech & Business","provider_url":"https://techandbusiness.org","title":"Vertex's Casgevy becomes first approved gene therapy for young kids with rare blood disorders","author_name":"T&B Newswire · Tech & Business","thumbnail_url":"https://static.biospace.com/dims4/default/5dbc1f4/2147483647/strip/true/crop/2235x1257+0+42/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fd0%2F51%2F2fef609a4bd9a8c0955fbb4d5ee1%2Fistock-1779962110.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;text-transform:uppercase;\">T&B NEWSWIRE · Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/1zexheHxKDYI99qGZra299\" style=\"color:#fff;text-decoration:none;\">Vertex's Casgevy becomes first approved gene therapy for young kids with rare blood disorders</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Vertex Pharmaceuticals said Wednesday the FDA approved a pediatric expansion of its gene therapy Casgevy for children 2 years and older with sickle cell disease and transfusion-dependent beta thalasse...</p>\n    </blockquote>"}